Doubt Over COVID-19 Vaccine Efficacy Weighing On Stocks Indicate ‘Economic Scarring?


11/29/2020

Concerns related to vaccine distribution have brought back the pandemic situation under focus whereby highlighting some of the grim realities of the world.



At the closing of the last week, Asian shares “stalled” close to “record highs” whereby reflecting the “renewed doubts” of the investors on the “highly-anticipated coronavirus vaccine” while they had hoped that some economic regions will see a quicker recovery in comparison to “their Western peers”.
 
The “MSCI’s broadest index of Asia-Pacific” showed that “shares outside Japan” slipped by “0.04%” yet remained closest to a “life-time peak” reached in the week. On the other hand, shares from Australia fell by “0.53%”, “Treasury Wine Estates Ltd” dipped by “11.25%” following China’s tariff imposition on “Australian wine” amid speculations of situation further worsening between “Beijing and Canberra”.
 
Nikkei of Japan, however gained by “0.33% in choppy trade”. China saw a surge in its industrial shares, similarly South Korea also witnessed a rise of “0.27%”. On the other hand, Reuters informed:
“U.S. S&P 500 e-mini stock futures fell 0.09%”.
 
While, “Euro Stoxx 50 futures” dropped by “0.26%”, “German DAX futures” dipped by “0.24%”, and “FTSE futures” also tumbled by “0.22%”, whereby indicating “soft start” for “European session”. Moreover, oil prices of the U.S. continued to decline post touching “a seven-month high” whereby indicating oversupply. AstraZeneca’s COVID-19 vaccine was seen as the “vaccine for the world” given its lower costs. However, the same has come under “intense scrutiny” over doubts on its efficacy possibly delaying its approval.
 
In a memo of ANZ Bank, analysts wrote:
“With global case numbers having now topped 60 million... there is certainly some rough terrain ahead for the global recovery, and that can create economic scarring”.
 
Concerns related to vaccine distribution have brought back the pandemic situation under focus whereby highlighting some of the grim realities of the world. With holiday seasons at doorsteps, experts fear infection as well as death rate increment. The nation-wide lockdown in England will end on December 2, 2020. However, over twenty million people from the country will have no other choice but to maintain “toughest restrictions” even post the lockdown period, whereby questioning the economic growth.
 
When the chief economist of ECB underscored the above mentioned concerns last week, the European bond showed lower yield. Currency traders, however, have largely geared up expecting for an “additional ECB easing next month”, while, index for dollar dropped to its “lowest” over two months.
 
 
References:
reuters.com